Patient Recruitment Case Study: Sickle Cell Disease and Beta Thalassemia - Stark / Raving Health
What are you looking for?

Patient Recruitment Case Study: Sickle Cell Disease and Beta Thalassemia

A series of phase 2 studies to evaluate the safety and tolerability of an investigational drug in subjects with the rare blood disorders Beta Thalassemia and Sickle Cell Disease

THE CLINICAL TRIAL
Forte and Ardent were conducted as dual clinical studies that sought to investigate the effectiveness of an investigational drug treating symptoms of Beta Thalassemia and Sickle Cell Disease, respectively. Beta Thalassemia is an inherited blood disorder in which the body does not produce the amount of beta globin that it needs, triggering severe anemia and causing a cascading effect of medical issues. Sickle Cell Disease is an inherited group of blood disorders that impact a person’s red blood cells—causing them to take on a sickle shape—and disrupting the flow of blood throughout the body causing lifelong medical issues. Both conditions significantly impact the quality of life for those who live with them.

 

THE PROJECT
For the Forte and Ardent studies, the Sponsor needed distinct branding elements to help drive patient recruitment and retention. Stark / Raving jumped in to provide direction on key messaging and creative elements that enhanced the look and feel of the brand, evoking a strong study identity within the site- and patient-facing materials for Forte and Ardent. Utilizing unique design elements, each study stands independently, with consideration given to how the materials would appear once translated and distributed around the globe.

Clinical study materials design for rare disease patient recruitment
Web design for rare disease clinical trial
Clinical study materials design for rare disease patient recruitment
Web design for rare disease clinical trial

Crafting impactful messages that resonate with diverse patient types.

Enrolling participants from 20 countries, many with varying levels of readership, the Forte and Ardent studies needed clear and simple messaging to successfully recruit participants from diverse global backgrounds. Stark / Raving assisted the Sponsor in crafting versatile, approachable messaging that provided patients and site staff members with a comprehensive overview of the clinical trials, delivered in easy-to-understand language crafted with the goal of creating a smooth and complete enrollment process for both studies.

Clinical study materials design for rare disease patient recruitment
Clinical study materials design for rare disease patient recruitment

Creating a unified brand identity to distinguish two distinct clinical trials.

Designing two distinct studies researching the same investigational product, we delivered bold, consistent brand elements to the Sponsor that could clearly identify each study independently while simultaneously weaving a thread through the materials linking them together. This strong brand architecture became the foundation for a full study toolkit of materials that provided doctors, site staff members, patients, and their caregivers with informational resources and reference materials to support a seamless study process.

Clinical study materials design for rare disease patient recruitment
Clinical study materials design for rare disease patient recruitment
Digital advertising for rare disease clinical trial
Clinical study materials design for rare disease patient recruitment
Digital advertising for rare disease clinical trial
Clinical study materials design for rare disease patient recruitment

Put our solutions to work for your next clinical trial.

Contact Us
Back Top